3'-galactosyllactose has been researched along with Influenza, Human in 1 studies
*Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braber, S; Cai, Y; Folkerts, G; Garssen, J; Hogenkamp, A; Kraneveld, AD; Leusink-Muis, T; Stahl, B; Tims, S; Toutounchi, NS; van Ark, I; Van't Land, B; Varasteh, S; Wehkamp, T; Wiertsema, S | 1 |
1 other study(ies) available for 3'-galactosyllactose and Influenza, Human
| Article | Year |
|---|---|
Human Milk Oligosaccharide 3'-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models.
Topics: Adaptive Immunity; Animals; Caco-2 Cells; Cecum; Diet; Fatty Acids, Volatile; Female; Food Contamination; Humans; Influenza, Human; Intestines; Mice, Inbred C57BL; Milk, Human; Mycotoxins; Oligosaccharides; Spleen; Th1 Cells; Trichothecenes; Trisaccharides; Vaccination; Vaccines | 2021 |